Oleg Pohotsky - Tekla Healthcare Independent Chairman of the Board of Trustees
| THQ Fund | USD 20.32 0.02 0.1% |
Mr. Oleg M. Pohotsky is Independent Trustees of Tekla Healthcare Opportunities Fund. Mr. Pohotsky is a corporate finance and investment professional with over forty years of diversified experience gained both in industry and in financial markets. Mr. Pohotsky serves as Chairman of the Board of Trustees of each Fund and also serves as Chairman of each Fund Valuation Committee and serves on each Fund Audit Committee. He has over 45 years of cumulative board experience in the full range of organization types publiclytraded, privatelyheld, venturebacked and nonprofit. He has also served as a director of a healthcare services company listed on the Nasdaq NMS where he was a member of the audit committee. In his various directorships he has also served on investment, compensation, personnel and executive committees. His career spanned over twenty years in the investment industry, both as an investment banker and as a VC and private equity investor, and included serving as chairman of the valuation and fairness opinion committee of a NYSEmember firm. Mr. Pohotsky also currently serves on the Board of Directors of Avangardco Investments Holdings, an LSElisted agribusiness enterprise based in Ukraine, on the board of directors of the New America High Income Fund, Inc., a closed end fund investing in high yield securities on a leveraged basis and on the Board of Advisors of Kaufman Co., LLC, a Bostonbased boutique investment banking firm, and is affiliated with GovernanceMetrics International, Inc. as a Senior Advisor. He provides each Fund with valuable experience in valuation and the financial industry
| Age | 73 |
| Tenure | 10 years |
| Professional Marks | MBA |
| Phone | 617 772 8500 |
| Web | https://www.teklacap.com/thq.html |
Tekla Healthcare Management Performance (%)
Similar Money Managers
| Showing other executives | One Year Return | ||
| Robert Steers | Cohen Steers Reit | 67 | |
| Robert Steers | Cohen Steers Qualityome | 67 | |
| Richard Cavanagh | Blackrock Resources Commodities | 75 | |
| Steven Pruchansky | John Hancock Financial | 76 | |
| Hans Kertess | Pimco Corporate Income | 82 | |
| Robert Steers | Cohen Steers Limited | 68 | |
| Jeremy May | Reaves Utility If | 49 | |
| Karen Robards | Blackrock Resources Commodities | 71 | |
| Jeremy Deems | Reaves Utility If | 43 | |
| Joseph Harvey | Cohen Steers Limited | 57 | |
| William Park | Eaton Vance Tax | 74 | |
| Joseph Harvey | Cohen Steers Reit | 57 | |
| James Oates | John Hancock Financial | 74 | |
| R Chadwick | Flaherty Crumrine Preferred | 44 | |
| Deborah DeCotis | Pimco Corporate Income | 69 | |
| Hassell McClellan | John Hancock Financial | 75 | |
Tekla Healthcare Opp Leadership Team
Elected by the shareholders, the Tekla Healthcare's board of directors comprises two types of representatives: Tekla Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tekla. The board's role is to monitor Tekla Healthcare's management team and ensure that shareholders' interests are well served. Tekla Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tekla Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Kent, Independent Trustee | ||
| William Reardon, Independent Trustees | ||
| Elizabeth Nabel, Independent Trustee | ||
| Oleg Pohotsky, Independent Chairman of the Board of Trustees | ||
| Laura Woodward, Chief Compliance Officer, Treasurer, Secretary | ||
| Lucinda Stebbins, Independent Trustees | ||
| Jeffrey Bailey, Independent Trustee | ||
| Daniel Omstead, President, Trustee | ||
| Rakesh Jain, Independent Trustees |
Tekla Fund Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right fund is not an easy task. Is Tekla Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Shares Outstanding | 41.34 M | ||||
| Shares Owned By Institutions | 19.54 % | ||||
| Number Of Shares Shorted | 14.15 K | ||||
| Price To Earning | 6.76 X | ||||
| Short Ratio | 0.14 X | ||||
| Earnings Per Share | 2.71 X | ||||
| Beta | 0.9 | ||||
| Market Capitalization | 951.66 M | ||||
| Annual Yield | 0.01 % | ||||
| Year To Date Return | 7.75 % |
Pair Trading with Tekla Healthcare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tekla Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tekla Healthcare will appreciate offsetting losses from the drop in the long position's value.Moving against Tekla Fund
| 0.56 | FTCAX | Templeton Strained Bond | PairCorr |
| 0.42 | PYARX | Payden Absolute Return | PairCorr |
| 0.42 | LTFOX | Lord Abbett Affiliated | PairCorr |
| 0.42 | GAB | Gabelli Equity Trust | PairCorr |
| 0.38 | PYAIX | Payden Absolute Return | PairCorr |
The ability to find closely correlated positions to Tekla Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tekla Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tekla Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tekla Healthcare Opportunities to buy it.
The correlation of Tekla Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tekla Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tekla Healthcare Opp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tekla Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Tekla Fund
Tekla Healthcare financial ratios help investors to determine whether Tekla Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tekla with respect to the benefits of owning Tekla Healthcare security.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |